Advent Capital Management’s Gilead Sciences GILD Stock Holding History

Advent Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-78,000	Closed	-$4.88M	–	227
2018 Q4	$4.88M	Sell	78,000 -35	-0%	-$2.45K	0.12%	130
2018 Q3	$6.03M	Buy	78,035 +8,035	+11%	+$607K	0.12%	131
2018 Q2	$4.96M	Hold	70,000	–	–	0.1%	153
2018 Q1	$5.28M	Buy	+70,000	New	+$5.56M	0.1%	161
2017 Q2	–	Sell	-44,300	Closed	-$3.01M	–	313
2017 Q1	$3.01M	Sell	44,300 -28,200	-39%	-$1.98M	0.06%	164
2016 Q4	$5.19M	Buy	72,500 +10,000	+16%	+$743K	0.1%	151
2016 Q3	$4.95M	Hold	62,500	–	–	0.07%	204
2016 Q2	$5.21M	Buy	62,500 +15,000	+32%	+$1.33M	0.08%	189
2016 Q1	$4.36M	Sell	47,500 -17,500	-27%	-$1.58M	0.07%	197
2015 Q4	$6.72M	Buy	65,000 +5,000	+8%	+$520K	0.1%	178
2015 Q3	$5.89M	Buy	60,000 +13,500	+29%	+$1.5M	0.09%	193
2015 Q2	$5.44M	Buy	46,500 +6,500	+16%	+$710K	0.08%	223
2015 Q1	$3.92M	Sell	40,000 -12,800	-24%	-$1.3M	0.06%	247
2014 Q4	$4.98M	Buy	+52,800	New	+$5.46M	0.07%	240
2014 Q2	–	Sell	-5,000	Closed	-$354K	–	470
2014 Q1	$354K	Buy	+5,000	New	+$392K	0.01%	421
2013 Q4	–	Hold	0	–	–	–	448

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Advent Capital Management's GILD Position: Q1 2019 in Review

Advent Capital Management sold out of Gilead Sciences (GILD) in Q1 2019, closing a stake of 78,000 shares — an estimated $4.88M sold.

Advent Capital Management first reported a position in GILD in Q1 2014 and held it in 15 quarters. The position peaked at $6.72M in Q4 2015. 1,491 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

Advent Capital Management reported no remaining Gilead Sciences position as of Q1 2019 after selling out during the quarter.
Advent Capital Management sold 78,000 Gilead Sciences shares in Q1 2019, an estimated $4.88M.
Advent Capital Management first reported a position in Gilead Sciences in Q1 2014 and held it in 15 quarters.
Advent Capital Management's Gilead Sciences position peaked at $6.72M in Q4 2015.
1,491 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on Advent Capital Management's 13F filing for Q1 2019, filed 15 May 2019.